UEHARA, S., VILLEE, C.A. and HosHIAI, H. Effect of Indomethacin and Prostaglandin F2a on Incorporation of [3H]Uridine by Preimplantation Mouse
Embryo. Tohoku J. exp. Med., 1984, 143 (3), [319] [320] [321] [322] [323] [324] [325] [326] Indomethacin, an inhibitor of prostaglandin synthesis, depressed the incorporation of [3H] uridine into RNA of mouse preimplantation embryo, when it was injected in vivo or added in vitro. In contrast, prostaglandin F2a decreased the inhibitory effect of indomethacin, when it was added in vitro with indomethacin. The results of these experiments suggest that prostaglandin F2a plays a role in the process of implantation and that the mouse preimplantation embryo may be able to produce prostaglandin F2a.
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It has been reported that prostaglandins are implicated in the implantation process in several mammalian species. Prostaglandin E2 is supposed to increase endometrial vascular permeability (Kennedy 1979 In contrast with the stimulatory effect of prostaglandins, an inhibitory action of indomethacin, a prostaglandin synthetase inhibitor (Flower and Vane 1974) , has been reported in many mammals (Castracane, Saksena and Hurst and McFarlane 1981) . Although those reports described the effect of indomethacin, all of them discussed about the effect of prostaglandins on implantation or growth of embryos because the major biological effects of indomethacin are due to its inhibition of prostaglandin synthesis. However, some investigators have considered that indomethacin does not reduce the number of implantation sites in rabbit (Hoffman 1978) or does not affect the early implantation changes of the blastocyst in mouse (Lundkvist and Nilsson 1980), but it interfered with the growth of embryo after implantation (Saksena and Harper 1974; Hoffman 1978) . Furthermore, some investigators have reported that indomethacin causes the delay of implantation (Hoffman 1977; Evans and Kennedy 1978) .
Although indomethacin is one of the interesting substances in the point of view that indomethacin is a prostaglandin synthetase inhibitor, its direct action on preimplantation embryos which may produce prostaglandins has not been well known. Therefore, the aim of the present study was to find out whether indomethacin injected in vivo or added in vitro has some effect on the incorporation of [3H] uridine into RNA in mouse preimplantation embryos. Moreover, as another aim, in order to examine the mechanism of the effect of indomethacin, studies were undertaken to determine whether prostaglandin F2a could counteract the effect of indomethacin.
MATERIALS AND METHODS

Superovulation
Virgin female CD-1 mice (6-9 weeks of age) were used and taken at various stages of the estrous cycle. Superovulation was induced by injecting 6 IU of pregnant mare serum gonadotropin (PMSG) followed by 10 IU of human chorionic gonadotropin (hCG). After the injection of hCG mice were placed with fertile male mice and the presence of a vaginal plug was determined the next morning (designated day 1 of pregnancy).
Injection of indomethacin to mice
Indomethacin, 100 p g, was injected subcutaneously in 0.1 ml of sesame oil into pregnant mice in the evening of day 2 and day 3 and in the morning of day 4. Control mice were injected with only 0.1 ml of sesame oil at the same time. On day 4, 3 hr later the last injection, mice were killed by cervical dislocation under ether anesthesia. Blastocysts were flushed from the uterine horns using a stream of Hanks balanced salt solution supplemented with 1 mg/ml of glucose and 10 ,u g/ml of gentamycin. The blastocysts were collected in small watch glasses and washed twice in Hanks solution before being radiolabeled. Then the blastocysts of the indomethacin treated group and the control group were divided into five groups. Each group consisted of 10-15 embryos and was placed in 500,ul of DMEM (Dulbecco's modified Eagle medium). This incubation medium was supplemented with 1 mg/ml of bovine serum albumin and 10 p g/ml of gentamycin and containing 20 ,u Ci/ml of [3H] uridine (specific activity, 42 Ci/mM, New England Nuclear). The blastocysts were incubated at 37°C under 5% CO2 in air for 4 hr.
Treatment of blastocysts with indomethacin in vitro
On day 4, about 90 hr after the injection of hCG, blastocysts were collected as described above. The blastocysts obtained from one mouse were randomly divided to each group. One group consisted of 10-25 embryos. Indomethacin was dissolved in ethanol and prepared at a concentration of 10 mg ml. This solution was then diluted with DMEM to give concentrations of 10 u g/ml and l p g/ml. Four groups were offered to examine the effect of one concentration of Indomethacin. The groups were placed in 500 ,u 1 of the medium, 20 u Ci/ml of [3H] uridine was added and the embryos were incubated in the same way. Two control and two treated groups were run as the groups of simultaneous incubations.
Treatment of blastocysts with indomethacin and prostaglandin FZa in vitro
Blastocysts were collected as described. Indomethacin solution was also prepared with the same method. Prostaglandin FZa (Sigma Chemical Co.) was dissolved with DMEM and added to prepare two kinds of mixture of l ,u g/ml of prostaglandin FZa plus 1,u g/ml of indomethacin and 10 g/ml of prostaglandin FZa plus 1 /1 g/ml of indomethacin. Groups of 10-25 embryos were placed in 500 1a l of the three kinds of medium [indomethacin alone (designated control) and two kinds of mixture of indomethacin and prostaglandin FZa] and incubated with [3H] uridine. Four groups were offered to examine the effect of one kind of the medium.
Assay for incorporation o f [3H1 uridine into RNA
At the end of the incubation period the tubes containing embryos were placed on ice and 1 ml of unlabeled uridine (10-4M) was added. The embryos were removed from the medium containing labeled uridine and transferred to 0.5 ml of ice cold phosphate buffered saline. The embryos were rinsed twice with the cold phosphate buffered saline. During the last rinse the number of embryos in each group was counted under the dissecting microscope. The embryos were then transferred to glass microfiber filters (24 mm diameter, Whatman GF/C) and washed extensively with ice cold 10% trichloroacetic acid, using the Milipore suction device. The filters were then rinsed with phosphate buffered saline to remove any free [3H] uridine and other [3H] uridine containing compounds except RNA. After these washes the filters were dried at room temperature overnight and the radioactivity of the acid insoluble material, RNA, was estimated by placing the filters in 10 ml of Aquasol 2 scintillation cocktail (New England Nuclear), and determining the radioactivity of these using a Packard model B460C liquid scintillation counter with an efficiency of 56% for tritium.
RESULTS
The numbers of counts per minute per embryo of the control groups were a little different in the each in vitro experiment because one in vitro experiment consisted of two subexperiments carried out on different days. To compare the results of a number of different experiments the radioactivities of the experimental groups were normalized and expressed as per cent of control. In the experiments in which indomethacin was injected in vivo, counts per minute per embryo was expressed without being normalized, because we used a large enough number of mice to compare the indomethacin treated group with control group in one experiment. The data of the radioactivities of the control groups and the treated groups were statistically compared by Student's t-test. Indomethacin injected to the mice in vivo significantly inhibited the incorporation of [11] 3uridine into RNA of preimplantation embryos, compared with non-indomethacin injected control groups (p<0.01) ( Table 1 ). The morphologic observation by the inverted microscope revealed that there was no difference between the embryos of the indomethacin injected groups and those of the control groups.
Indomethacin administered to embryos in vitro also significantly inhibited the incorporation of [3H] uridine into RNA ( Table 2 ). Both concentrations of indomethacin significantly inhibited (p<0.005), but the inhibition produced by 1 ,ug/ml of indomethacin was less than the effect of 10,ug/ml.
In contrast with the inhibitory effect of indomethacin, l pg/ml and 10 pg/ml of prostaglandin F2a counteracted this and increased the incorporation of [II] 3 uridine. The effect of 1 pg/ml of prostaglandin F2a was more than that of 10 pg/ ml. This stimulatory effect of prostaglandin F2a was significant (p <0.005), compared with the groups to which no prostaglandin was added (Table 3) .
DISCUSSION
The preimplantation embryo is affected by many substances in the uterine lumen through the implantation period. Prostaglandins are synthesized by the endometrium that is stimulated with estrogen ( (Kennedy 1979 ) and decidualization (Sananes et al. 1976; Hoffman et al. 1977 ) is recognized as an indirect stimulator of embryonal implantation. In contrast with prostaglandin E2, prostaglandin F2a has little effect on endometrial vascular permeability (Kennedy 1979 ) and decidualization (Sananes et al. 1976 ).
In recent years some investigators claimed that prostaglandins can be produced by the rabbit embryo (Dickmann and Spilman 1975; Dey et al. 1980; Sharma 1980; Harper et al. 1983 ). In other mammals the embryonal production of prostaglandins has not been detected, but it is to be expected that not only rabbit but other mammalian embryos have possibility of prostaglandins production.
Indomethacin has been known to inhibit the activity of some enzymes including prostaglandin synthetase (Flower and Vane 1974) , and reduces the biosynthesis of prostaglandins in each organ (Vane 1971 Rankin et al. 1979 ). Although others have described this inhibitory action of indomethacin, they claimed that indomethacin does not reduce the number of implantation site but affects the embryonal growth after implantation (Hoffman 1978 ; Lundkvist and Nilsson 1980) . Furthermore, it has been demonstrated that indomethacin treatment delays implantation without reducing serum progesterone level and uterine blood supply (Kennedy 1977 ; Evans and Kennedy 1978 ; Hoffman et al. 1978) or with reducing progesterone level (Phillips and Poyser 1981) . In addition to the inhibitory effects of indomethacin on uterine prostaglandin biosynthesis, indomethacin reduces the embryonal prostaglandin F2a production in the rabbit (Harper et al. 1983 ).
The present study revealed that indomethacin, whether injected in vivo, or added in vitro, has an inhibitory effect on the incorporation of [3H] uridine into RNA of preimplantation embryo in the mouse. The dosage of indomethacin used in the present experiments was not higher than that of previous reports. This suggests that indomethacin affects the metabolism of the embryo even before implantation. However, it cannot be determined whether the mechanism of inhibitory effect of indomethacin injected in vivo is the same as that of indomethacin added in vitro. Indomethacin, injected in vivo, may decrease the synthesis of prostaglandins in the uterus and the synthesis of prostaglandins by the embryos and reduce other uterine and embryonal enzymes, such as prostaglandin dehydrogenase, phosphodiesterase and DOPA decarboxylase (Flower and Vane 1974) . Indomethacin, added in vitro, may also show these actions except decreasing uterine prostaglandin synthesis. Some investigators have reported an in vitro inhibitory effect and found that indomethacin added in vitro inhibited the hatching of mouse embryo (Biggers et al. 1978 ; Hurst and McFarlane 1981) . The mechanism of the inhibition of hatching was considered as follows : The endogenous prostaglandins were decreased by indomethacin, so that the expansion of blastocyst could not occur (Biggers et al. 1978) . In order to study further the mechanism of the in vitro inhibitory effect of indomethacin on the incorporation of [3H] uridine into RNA, the incorporation rate of embryos incubated in a medium containing indomethacin and prostaglandin F2a was compared with that of embryos incubated in a medium containing indomethacin alone. Exogenously added prostaglandin F2a could overcome the inhibitory effect of indomethacin. This suggests that the exogenous prostaglandin F2a substituted for the decreased endogenous prostaglandin F2a production. However, 10 jig/ml of prostaglandin F2a has less effect than 1 jig/ml. It is one reason of this that the 10 jig/ml of prostaglandin F2a might be too high as a physiological concentration.
It has been demonstrated that indomethacin does reduce the activitites of enzymes other than prostaglandin synthetase (Flower and Vane 1974) . Although a high concentration of indomethacin is needed to reduce those enzyme, we can consider the possibility that indomethacin inhibited those enzymes and depressed the metabolism of embryo and that exogenously added prostaglandin F2a stimulated the incorporation of uridine without having any relation to embryonal prostaglandins production. Therefore, we can conclude that prostaglandins are involved in initiating the implantation process, but the mechanism of the effect of Indomethacin and prostaglandin F2a on the process and the production of prostaglandins in the mouse embryo remain unclear.
